Lactose India Standalone December 2020 Net Sales At Rs 10.28 Crore, Up 3.3% Y-o-Y

Hasn't faired well - amongst the low performers

Performance

Seems to be overvalued vs the market average

Valuation

Financials growth has been moderate for a few years

Growth

Showing good signs of profitability & efficiency

Profitability

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

The stock has a moderate number of red flags

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Lactose India Limited is a pharmaceutical company engaged in the business of manufacturing pharmaceutical products. The Company is principally engaged in manufacturing of lactose monohydrate

Lactose India Ltd

Lactose India Ltd

Scorecard

News & Opinions

Lactose India Standalone December 2020 Net Sales At Rs 10.28 Crore, Up 3.3% Y-o-Y